Røder, Michael E <br/><br/>
Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential.  [electronic resource] 

 -  Therapeutic advances in chronic disease  Jan 2018 
 - 33-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2040-6223 
<br/><br/><label>Standard No.: </label>10.1177/2040622317735283  doi